• Apple Cold Signaling: MdOST1–MdCNGC1C–MdCaM7.1

  2026-08-28

  The 2026 study identifies a competitive MdOST1–MdCNGC1C–MdCaM7.1 module that controls cold-induced calcium influx and freezing tolerance in apple. Its key contribution is a feedback model in which MdOST1 phosphorylation activates the channel, whereas Ca2+-dependent MdCaM7.1 binding helps restrain signaling, offering a mechanistic framework for protein phosphorylation signaling during cold stress.

• HLY78: Designing Better Wnt Signaling Assays

  2026-08-27

  HLY78 is a Wnt/β-catenin pathway modulator that enables ligand-dependent pathway interrogation rather than nonspecific endpoint activation. This article explains how to apply its Axin-centered mechanism when interpreting developmental and fibrosis-related experiments.

• Vitamin C (CAS 50-81-7): Evidence Guide

  2026-08-27

  Vitamin C, also called ascorbic acid, is a water-soluble compound used in cancer and cellular-senescence research. Product-dossier data report concentration-dependent effects in CT26 cells, while a 2024 study links protection of HEI-OC1 cochlear cells to suppression of the ROS/NF-κB pathway.

• Actinomycin D Workflows for AML RNA Stability

  2026-08-26

  Learn how Actinomycin D converts transcriptional shutdown into measurable RNA-decay, apoptosis, and transcriptional-stress endpoints in AML models. This workflow-focused guide connects WTAP–m6A–MYC biology with practical dosing, sampling, controls, and troubleshooting.

• Z-VEID-FMK in Caspase-6 Apoptosis Workflows

  2026-08-26

  Z-VEID-FMK provides a cell-permeable, irreversible way to test whether caspase-6 contributes to stimulus-induced apoptosis. This workflow also shows how to distinguish caspase-6-dependent apoptosis from the caspase-1/GSDMD pyroptosis mechanism identified in recent NSCLC research.

• Maraviroc Workflows for CCR5 Research

  2026-08-25

  Maraviroc, also known as UK-427857, supports precise CCR5 perturbation across HIV-1 entry inhibition, HIV tropism studies, and inflammatory cell models. This workflow-oriented guide translates a recent extracellular-vesicle rheumatoid arthritis study into practical assay design, dosing, controls, and troubleshooting decisions.

• Edible Bird’s Nest Peptide and Skin Repair

  2026-08-25

  The reference study identifies edible bird’s nest peptide as a bioactive hydrolysate with EGF-associated, extracellular-matrix, and anti-inflammatory effects in cell and zebrafish wound-healing models. Its main contribution is integrating tissue-repair, ECM gene-expression, oxidative-stress, cytokine, and neutrophil findings to explain how the peptide may support regeneration, while its preclinical design still limits direct translation to human skin therapies.

• GANT61 Targets Hh–PIK3IP1–Akt in ALK+ ALCL

  2026-08-24

  The 2026 Annals of Hematology study identifies a potential connection between Gli1 inhibition, PIK3IP1 restoration, and attenuation of Akt signaling in ALK-positive anaplastic large cell lymphoma. Its integrated use of proliferation, flow cytometry, transcriptomic, and molecular assays supports a mechanistic model in which GANT61 suppresses lymphoma growth through cell-cycle arrest and apoptosis, while also highlighting important limits of pharmacologic and in-vitro evidence.

• Sumatriptan Metabolism Revisited: CYP and MAO Roles

  2026-08-24

  The reference study challenges the conventional view that sumatriptan is metabolized mainly through monoamine oxidase A, showing that selected cytochrome P450 isoforms also generate N-desmethyl and N,N-didesmethyl metabolites. Its enzyme-resolved HPLC-MS strategy provides a useful framework for distinguishing parallel N-demethylation and oxidative deamination pathways in drug metabolism studies.

• NADH: A Translational Redox Control Point

  2026-08-23

  NADH is more than an energy-metabolism reagent: it is a controllable readout and mechanistic lever linking redox balance, mitochondrial respiration, SIRT1 activity, HIF-1α signaling, and oxidative stress. This thought-leadership guide uses catalpol protection against triptolide-induced liver injury as a translational case study, then outlines how researchers can position NADH measurements and interventions within disease models without overstating the evidence.

• α2-Adrenergic Receptor Agonist Workflow

  2026-08-22

  Build reproducible α2-AR signaling assays with a DMSO-soluble research agonist suited to receptor, immune co-culture, and formulation workflows. The approach separates direct osteosarcoma-cell effects from immune-mediated responses while translating a recent hydrogel study into practical bench decisions.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-08-22

  Learn how to apply the One-step TUNEL Cy3 Apoptosis Detection Kit to DNA fragmentation analysis in tissue sections, adherent cells, suspension cells, and flow-cytometry workflows. The guide connects practical assay design with glioblastoma apoptosis research, including controls, imaging choices, and troubleshooting strategies.

• ETS1–SENP2–HSPA8 Controls Mitophagy in BPD

  2026-08-21

  The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation of FUNDC1 and HSPA8-mediated degradation. Its findings connect transcriptional control, mitochondrial quality control, and chaperone-linked autophagy, while providing a mechanistic framework for interpreting autophagy pathway modulation in lung injury models.

• Dehydroabietic Acid in Ferroptosis-Aware Metabolism

  2026-08-20

  Dehydroabietic acid is a dual PPAR-α/γ agonist with potential value in metabolic disorder research. This article presents a ferroptosis-aware assay framework that separates receptor-driven lipid remodeling from glutamine-dependent antioxidant defenses in hepatocellular carcinoma models.

• EZ Cap™ Cas9 mRNA (5-moUTP) Gene Editing Workflows

  2026-08-20

  Use transient Cas9 delivery to test Fyn–Stat3 mechanisms, optimize zebrafish neurodegeneration models, and build controlled functional gene studies. This workflow combines capped, modified mRNA handling with orthogonal editing, imaging, and inflammatory readouts rather than relying on phenotype alone.

7691 records 1/513 page Next 12345 下5页 Last page